Hyperlipidemia in children and adolescents

American Heart Journal

Volumn 142, Issue 3, 2001, Pages 433-439

  Valente, Anne Marie ^a,b,c   Newburger, Jane W ^a,b,c   Lauer, Ronald M ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COLESTIPOL; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ATHEROGENESIS; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CORONARY ARTERY DISEASE; DIET THERAPY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FOLLOW UP; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; MASS SCREENING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION;

EID: 0034863710     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.117829     Document Type: Conference Paper

References (53)

1. Prevention of cardiovascular events and death with pavastatin in patients with coronary heart disease broad range of initial cholesterol levels
2. Plan and operation of the Health and Nutrition Examination Survey, United States 1971-73
3. Plan and operation of the second National Health and Nutrition Examination Survey: 1976-80
4. Sample design: Third National Health and Nutrition Examination Survey
5. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: Data from the Third National Health and Nutrition Examination Survey
6. Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: A review study
7. Hyperlipidemia in coronary heart disease, II: Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipedemia
8. Familial combined hyperlipidemia in children: Clinical expression, metabolic defects and management
9. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults
10. Familial hypercholesterolemia
11. Inherited dyslipidemias in childhood
12. Prevention of coronary heart disease report of a WHO expert committee Geneva (Switzerland) World Health Organization
13. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: The Bogalusa Heart Study
14. Coronary disease among United States soldiers killed in action in Korea
15. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations, preliminary report
16. Cholesterol screening in childhaod: Does it predict adult hyperchalesterolemia? The Beaver County experience
17. Factors affecting the relationship between childhood and adult cholesterol levels: The Muscatine Study
18. Report of the expert panel on blood cholesterol levels in children and adolescents
19. Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children
20. Family history evaluation as a predictive screen for childhood hypercholesterolemia
21. The child as proband: High prevalence of unrecognized and untreated hyperlipidemia in parents of hyperlipidemic children
22. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol
23. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine
24. Treatment of familial hypercholesterolemia with drugs in children
25. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
26. Use of cholestyramine in treatment of children with familial combined hyperlipidemia
27. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial
28. Niacin treatment of hypercholesterolemia in children
29. Double blind trial of bezafibrate in familial hypercholesterolemia
30. Treatment of familial hypercholesterolemia in children and adolescents: Effect of lovastatin
31. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia
32. Efficacy and safety of lovastatin in adolescent males with familial hypercholesterolemia: A randomized controlled trial
33. Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterotemia in childhood
34. Management of hyperlipidemia in children with refractory nephrotic syndrome: The effect of statin therapy
35. Structural maturation of neural pathways in children and adolescents: In vivo study
36. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging
37. Increased intima-media thickness of the common carotid artery in hypercholesterolemic children
38. Ultrasonographic evaluation of cardiac and vascular changes in young boderline hypertensives
39. Carotid artery wall changes in young type-1 diabetics: The ultrasonic diagnosis of early arteriosderosis
40. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in young healthy adults
41. Carotid intima-media thickness in young patients with familial hypercholesterolemia
42. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The Muscatine Study
43. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
44. Restoration of endothelium-dependent relaxation by dietary treatment of atherosderosis
45. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to lipoprotein (a) level
46. Lowering plasma homocysteine improves brachial arterial vasoreactivity in patients with coronary artery disease
47. Endothelial dysfunction in insulin-dependent diabetes relates to the duration of disease and the LDL-cholesterol level
48. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: Improvement with antioxidant vitamin therapy
49. Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia
50. Coronary calcium, as determined by electron beam computed tomography, and coronary disease on arteriogram: Effect of patient's sex on diagnosis
51. Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications: A statement for health professionals from the American Heart Association
52. Potential of quantity of coronary artery calcification to identify new risk factors for asymptomatic atherosclerosis